One of the fundamental questions concerning expression and function of dimeric enzymes involves the impact of naturally occurring mutations on subunit assembly and heterodimer activity. This question is of particular interest for the human enzyme galactose-1-phosphate uridylyltransferase (GALT), impairment of which results in the inherited metabolic disorder galactosemia, because many if not most patients studied to date are compound heterozygotes rather than true molecular homozygotes. Furthermore, the broad range of phenotypic severity observed in these patients raises the possibility that allelic combination, not just allelic constitution, may play some role in determining outcome. In the work described herein, we have selected two distinct naturally occurring null mutations of GALT, Q188R and R333W, and asked the questions (i) what are the impacts of these mutations on subunit assembly, and (ii) if heterodimers do form, are they active? To answer these questions, we have established a yeast system for the coexpression of epitopetagged alleles of human GALT and investigated both the extent of specific GALT subunit interactions and the activity of defined heterodimer pools. We have found that both homodimers and heterodimers do form involving each of the mutant subunits tested and that both heterodimer pools retain substantial enzymatic activity. These results are significant not only in terms of their implications for furthering our understanding of galactosemia and GALT holoenzyme structure-function relationships but also because the system described may serve as a model for similar studies of other complexes composed of multiple subunits.One of the fundamental questions raised by studies of the human enzyme galactose-1-phosphate uridylyltransferase (EC 2.7.7.12; GALT) concerns the role of subunit interaction on holoenzyme function and the impact of naturally occurring mutations on those interactions. Human GALT, impairment of which results in the potentially lethal disorder galactosemia, has been demonstrated to function as a dimer (1-7), ostensibly composed of identical subunits. However, the marked heterogeneity of naturally occurring point mutations identified in the GALT loci of galactosemia patients (e.g., ref. 8) indicates that many, if not most, of these patients are compound heterozygotes rather than true molecular homozygotes. The GALT enzymes expressed in these individuals, therefore, would be expected to consist of mixtures of homodimers and compound heterodimers, present in proportions reflective of the relative abundance, stability, and affinities of the individual subunits involved. This added level of heterogeneity may contribute to the broad range of phenotypic severity (for review, see ref. 9) observed for patients with galactosemia.